FI931346A0 - Butadienderivat och foerfarande foer deras framstaellning - Google Patents

Butadienderivat och foerfarande foer deras framstaellning

Info

Publication number
FI931346A0
FI931346A0 FI931346A FI931346A FI931346A0 FI 931346 A0 FI931346 A0 FI 931346A0 FI 931346 A FI931346 A FI 931346A FI 931346 A FI931346 A FI 931346A FI 931346 A0 FI931346 A0 FI 931346A0
Authority
FI
Finland
Prior art keywords
group
formula
substituted
butadienderivat
lower alkoxy
Prior art date
Application number
FI931346A
Other languages
English (en)
Other versions
FI931346A (fi
Inventor
Tameo Iwasaki
Takashi Nishitani
Akio Ohtani
Masanori Inamasu
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4119481A external-priority patent/JP2541421B2/ja
Priority claimed from JP4119480A external-priority patent/JP2541420B2/ja
Priority claimed from JP4119482A external-priority patent/JP2564781B2/ja
Priority claimed from JP4119483A external-priority patent/JP2595931B2/ja
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of FI931346A0 publication Critical patent/FI931346A0/fi
Publication of FI931346A publication Critical patent/FI931346A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C243/30—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C07C243/32—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
  • Reinforced Plastic Materials (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Materials For Medical Uses (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI931346A 1992-03-26 1993-03-26 Butadienderivat och foerfarande foer deras framstaellning FI931346A (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP4119481A JP2541421B2 (ja) 1992-03-26 1992-03-26 ３−ブテン酸誘導体及びその製法
JP4119480A JP2541420B2 (ja) 1992-03-26 1992-03-26 ３−ブテン酸誘導体及びその製法
JP4119482A JP2564781B2 (ja) 1992-03-26 1992-03-26 ２，５−ピロリジンジオン誘導体及びその製法
JP4119483A JP2595931B2 (ja) 1992-03-26 1992-03-26 ２，５−ピロリジンジオン誘導体及びその製法

Publications (2)

Publication Number Publication Date
FI931346A0 true FI931346A0 (fi) 1993-03-26
FI931346A FI931346A (fi) 1993-09-27

Family

ID=27470596

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931346A FI931346A (fi) 1992-03-26 1993-03-26 Butadienderivat och foerfarande foer deras framstaellning

Country Status (11)

Country Link
US (2) US5514815A (fi)
EP (1) EP0563798B1 (fi)
CN (1) CN1078720A (fi)
AT (1) ATE154344T1 (fi)
AU (1) AU658271B2 (fi)
DE (1) DE69311419T2 (fi)
DK (1) DK0563798T3 (fi)
ES (1) ES2104985T3 (fi)
FI (1) FI931346A (fi)
GR (1) GR3023808T3 (fi)
IL (1) IL105124A0 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY118876A (en) 1996-03-29 2005-02-28 Tanabe Seiyaku Co Butadiene derivatives and process for preparing thereof
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
CA2569958C (en) 2004-06-12 2016-03-22 Jane C. Hirsh Abuse-deterrent drug formulations
US8853257B2 (en) 2005-11-21 2014-10-07 Mordechai Sharir Succinimide derivatives as ocular hypotensive agents
US20090318515A1 (en) * 2005-11-21 2009-12-24 Mordechai Sharir Succinimide derivatives as ocular hypotensive agents
WO2009001949A1 (ja) 2007-06-27 2008-12-31 Kowa Company, Ltd. ピラゾロン誘導体
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
SG10201510564PA (en) 2010-12-22 2016-01-28 Purdue Pharma Lp Encased tamper resistant controlled release dosage forms
ES2581323T3 (es) 2010-12-23 2016-09-05 Purdue Pharma Lp Formas de dosificación oral sólida resistentes a alteraciones
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
CN108059598A (zh) * 2016-11-08 2018-05-22 华东理工大学 由巴豆酸衍生物制备多取代二烯烃的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1442628A (en) * 1973-09-01 1976-07-14 Heller H G Photochromic compounds
US4145536A (en) * 1973-09-01 1979-03-20 Heller Harold G Photochromic compounds
US4182629A (en) * 1973-09-01 1980-01-08 Heller Harold G Photochromic compounds
GB2104504B (en) * 1981-07-16 1985-05-09 English Clays Lovering Pochin Stabilisation of photochromic fulgides and fulgimides
JP2588013B2 (ja) * 1987-12-29 1997-03-05 吉富製薬株式会社 ブタジエン化合物およびその医薬用途
EP0420397B1 (en) * 1989-07-28 1995-11-29 Wako Pure Chemical Industries Ltd Fulgimide derivatives

Also Published As

Publication number Publication date
EP0563798B1 (en) 1997-06-11
CN1078720A (zh) 1993-11-24
US5639789A (en) 1997-06-17
ES2104985T3 (es) 1997-10-16
DE69311419D1 (de) 1997-07-17
AU658271B2 (en) 1995-04-06
DE69311419T2 (de) 1997-11-06
US5514815A (en) 1996-05-07
AU3525093A (en) 1993-09-23
ATE154344T1 (de) 1997-06-15
FI931346A (fi) 1993-09-27
GR3023808T3 (en) 1997-09-30
DK0563798T3 (da) 1997-07-07
EP0563798A1 (en) 1993-10-06
IL105124A0 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
SE8201854L (sv) N-substituerade amino-aminosyror
AU591640B2 (en) Quinolonecarboxylic acid derivatives
FI931346A0 (fi) Butadienderivat och foerfarande foer deras framstaellning
IL100289A0 (en) N-iodopropargyloxycarbonyl amino acid esters and derivatives,their preparation and their use as antimicrobial agents
IL77717A (en) Pharmaceutical compositions containing derivatives of imidazole,their preparation and some novel compounds of this type
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
ES2065994T3 (es) Beta-dicetonas substituidas.
IL85768A0 (en) Benzoxazine derivatives,their preparation and pharmaceutical compositions containing them
CA2092919A1 (en) Epoxysuccinamic acid derivatives
ES556048A0 (es) Un procedimiento para la preparacion de un derivado de tiazolidina.
ES2059451T3 (es) Derivados de naftotiazepina y su procedimiento de preparacion.
ES8602789A1 (es) Procedimiento para preparar derivados de 14-hidroxiimino- eburnano racemicos y opticamente activos
MY101746A (en) 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof.
ES8307812A1 (es) Un procedimiento para la preparacion de nuevos amidin derivados del acido clavulawilo.

Legal Events

Date Code Title Description
FD Application lapsed